Related Experiment Video
Updated: Oct 11, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
Hypersensitivity to polyethylene glycol in adults and children: An emerging challenge
Annamaria Bianchi1, Paolo Bottau2, Elisabetta Calamelli3
1UOC Pediatria, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense 87, Roma, 00152 Italy. annamaria.bianchi9@yahoo.it.
Insights
Hypersensitivity reactions to polyethylene glycol (PEG) are an increasing concern, particularly with COVID-19 vaccines. This review highlights diagnostic challenges and proposes management strategies for patients experiencing PEG allergies.
Area of Science:
- Immunology
- Pharmacology
- Allergy
Background:
- Polyethylene glycol (PEG) is a common ingredient in pharmaceuticals, cosmetics, and food products.
- PEG hypersensitivity is an emerging issue, linked to anaphylaxis following COVID-19 vaccination.
- Inconsistent nomenclature and labeling complicate the identification of PEG in products.
Purpose of the Study:
- To review reported cases of hypersensitivity reactions to PEG.
- To propose a standardized allergy work-up protocol for suspected PEG allergy.
- To outline management strategies for patients with PEG hypersensitivity.
Main Methods:
- Literature review of published cases of PEG hypersensitivity.
- Analysis of diagnostic approaches and clinical presentations.
- Development of a proposed allergy work-up and management plan.
Main Results:
- PEG is a frequent excipient in various medications, often unlabelled.
- Patients may experience recurrent reactions due to unrecognized PEG exposure.
- Diagnostic challenges include lack of standardized testing and product information.
Conclusions:
- Accurate diagnosis of PEG hypersensitivity requires awareness and systematic investigation.
- Standardized allergy work-up and clear product labeling are crucial for patient safety.
- Effective management involves avoidance of PEG and appropriate therapeutic interventions.
Abstract:
Hypersensitivity reactions to polyethylene glycol (PEG) is an emerging challenge and the interest about this disease is growing since PEG is considered one of the possible causes of coronavirus disease 2019 (COVID 19) vaccine-associated anaphylaxis. PEG is used in a wide variety of pharmaceutical, medical, industrial, cosmetic, and food products and can be an active ingredient or used as an excipient. PEG is present in several medications, and it may or may not be present in different formulations and dosages of the same drug. Lack of standardization nomenclature, inadequate labelling of products and lack of knowledge about PEG involvement in hypersensitivity reactions expose patients at risk of presenting multiple reactions before a diagnosis could be made. In this review we describe the main cases published in literature and propose an allergy work-up and management.
More Related Videos
11:32Characteristics of Precipitation-formed Polyethylene Glycol Microgels Are Controlled by Molecular Weight of Reactants
Published on: December 23, 2013
15:33Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
Published on: October 29, 2013
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Geriatric Patients
Pharmacokinetics in Pediatric Patients: Drug Distribution
Factors Affecting Drug Response: Overview